Navigation Links
NeurogesX Added to Russell 3000 Index
Date:6/29/2009

SAN MATEO, Calif., June 29 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX) announced today that it has been added to the broad-market Russell 3000(R) and small-cap Russell(R) 2000 Indexes. The addition became effective at the close of market June 26, 2009 when Russell Investments reconstituted its U.S. and global equity indexes.

Annual reconstitution of Russell's U.S. indexes captures the 4,000 largest U.S. stocks as of the end of May, ranking them by total market capitalization. Inclusion in the Russell 3000, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000(R) Index or small-cap Russell 2000(R) Index as well as the appropriate growth and value style indexes. The Russell 3000 also serves as the U.S. component to the Russell Global Index, which Russell launched in 2007. Russell determines membership for its equity indexes primarily by objective, market-capitalization rankings and style attributes.

Anthony DiTonno, CEO of NeurogesX, commented, "We welcome the addition of NeurogesX to the Russell 3000 index, which is well timed with our ongoing transition into a commercial-stage biopharmaceutical company. With several upcoming milestones surrounding our lead product Qutenza(TM), including the launch in Europe and potential for a US approval, our inclusion in the index could potentially provide exposure for the Company to a broader base of institutional investors that use the indices to benchmark their portfolios.

Russell indexes are widely used by investment managers and institutional investors for index funds. An industry-leading $4 trillion in assets are currently benchmarked to them for both passive and active investment strategies.

About NeurogesX, Inc.

NeurogesX (Nasdaq: '/>"/>

SOURCE NeurogesX, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BEIJING, Nov. 25 /PRNewswire-Asia/ -- Sin...provider of vaccines, announced today that it exec...inovac (Dalian) Vaccine,Technology Co., Ltd. (Sino...e,and commercialize human-use vaccines. Sinovac wi...loping and commercializing world-class vaccines; t...
(Date:11/25/2009)...AN DIEGO, Nov. 25 Ardea ... that Barry D. Quart, Pharm.D., president and chie...fray 21st Annual Health Care Conference. , ,Prese...t Annual Health Care Conference,Date: Tuesday...me,Location: The New York Palace Hotel, New York,...
(Date:11/24/2009)..., HOUSTON, Nov. 24 IES (...ectrical and communications systems and services f...ets, announced today that its commercial business ...orcon JV to install the electrical systems for the...ty at the U.S. Army Medical Research Institute of ...
(Date:11/24/2009)... The New York investment bank KTA Capit...as agreed an AU$6.7 mil convertible note private p...rivate placement was arranged by KTA Capital as Ne... New York (PRWEB) November 2...k KTA Capital, LLC ("KTA Capital") has a...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...any Licenses Septin-9 DNA Methylation Biomarker fr...gnostics,Incorporated (NYSE: DGX ), the leading p...ices, today announced that it has licensed rights ...from Epigenomics AG,(Frankfurt, Prime Standard: EC...lop a molecular-based laboratory test that can hel...
...YORK, Feb. 19 Cowen Group, Inc. (Nasdaq:,COWN) an...nced today that,Matthew Q. Reber has been hired as...r is based in Connecticut and rejoins founders Gre...the Managing Directors of CHRP,with whom he previo...oining CHRP, Mr. Reber worked at Accretive LLC, a ...
...ARBOR, Mich., Feb. 19 MichBio, the association fo... chairman and chief,executive officer of Allegan, ...or its April 22 Annual Meeting in Ann Arbor. Papa,...for Quality, Affordable Healthcare,Products.", Pa... chief executive,officer. He was elected to the co...
Other Biology Technology:Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 2Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 3Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer 4Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team 2MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop 2
(Date:11/26/2009)...itehead researchers have developed a new type of g... genes and proteins used by pathogens, according t... cultures genes are present in two copies: one inh...ne inactivation by mutation is therefore inefficie...d copy usually remains active and takes over. , ...
(Date:11/25/2009)...ch, may be used to boost resistance to, or slow, t... of Medicine researchers report in a study publish...ce . , Parkinson,s disease is caused by a degene...ain known as the substantia nigra, which is respon... of dopamine in late-stage Parkinson,s causes symp...
(Date:11/25/2009)...the linchpin of the environment, where atmosphere,...ny students see soil as "just dirt" a place to gr...s are challenged with the task of helping students...of soil in the environment. , A collaborative p...at University of Nebraska-Lincoln, Oregon State Un...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 1National Alliance for Hispanic Health President and CEO Applauds House Action Calls on Senate to Pass Health Reform in 2009 60914 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 1PhRMA Statement on House Passage of Health Care Reform Bill 60912 2PhRMA Statement on House Passage of Health Care Reform Bill 60912 3Stupak Amendment Passes in Final House Health Care Bill A First Step to Victory but Many Battles Ahead We Must Rejoice With Caution 60910 1
... CHICAGO -- A spinal cord injury often leads to pe...site of the injury because the damaged nerve fiber... the capacity to grow again, but dont because they...e injury. , Northwestern University researchers ...s the formation of scar tissue at the injury site ...
... This release is available in German . , , Hal... with nitrogen could be lowered in future. Soil sc... Research (UFZ) have developed a new mathematical ...ons for microbiological water treatment. Using the...tical model, which is the most accurate to date, c...
... The bombardier beetle is inspiring designers of e...rs to improve spray technologies, writes Andy McIn...f Swedish Biomimetics 3000 Ltd, in Aprils Physics ...frica and Asia, is remarkable in that it can fire ...edators such as birds and frogs. While the chemic...
Other Biology News:Promising new nanotechnology for spinal cord injury 2New formula for combating the greenhouse gas nitrous oxide 2New formula for combating the greenhouse gas nitrous oxide 3New formula for combating the greenhouse gas nitrous oxide 4The bombardier beetle, power venom and spray technologies 2
Equine TNF-alpha / TNFSF1A, Unconjugated from R&D Systems
...ng Checker Kits provide two highly efficient metho...formation without time-consuming plasmid preparati...I, all you need to do is to transfer partial colon...mation plates into the solutions provided by the k...
GRADIENT MAKER, 30 ML from GE Healthcare, formerly Amersham Biosciences
...and G. Butcher (1998). • The major histocompa...n the immunology area. There is great interest in ...n as antigen-presenting molecules. Many immunology...biochemical and genetic techniques in order to stu...
Biology Products: